Quiz of the day

Combination of thienopyridines and PPIs: what’s the risk?

  • 24 september 2018Hard
In patients treated with a thienopyridine antiplatelet medication (e.g., ticlopidine, clopidogrel, prasugrel), compared to treatment without proton pump inhibitors (PPI), co-administration of the latter may be associated with an increase in the relative risk (RR) of:

0
CHALLENGERS

Ends in

0 Months
0 Months
0 hours
0 of 0 answered questions

Laddar …